ArticleBMC ophthalmology2026

WT1-pulsed dendritic cell vaccination for neovascular age-related macular degeneration: a phase I pilot feasibility study.

Masaki Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.